NEOG - Neogen Corp - Insider Stock Trading

TC	Stat	Stk	Ins	Fil	+d	+w	+m	+q	+h	+y	avg
P	%ret	1	11	29	1	-1	1	9	10	25	7
P	%wins				72	48	55	83	62	83	67

Filing Date	T Date	Ticker	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	L	Qty	oc	Own	H	r2y	r1y	r6m	r3m	r6w	r3w	r7d	r3d	f1d	f1w	f1m	f3m	f6m	f1y
4/17/24 12:04	4/17/24	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Jones Douglas Edward	MI	O	COO	P	124	12.36	0	10	28	46	D
4/11/24 11:40	4/11/24	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Borel James C	DE	D		P	98	13.06	0	8	54	21	D
4/10/24 16:18	4/10/24	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Naemura David H.	MI	O	CFO	P	156	12.51	0	13	71	30	D
4/10/24 14:25	4/10/24	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Adent John Edward	MI	O	CEO	P	284	12.36	0	23	18	152	D
11/3/23 13:59	11/3/23	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Boehm William T		D		P	32	16.06	0	2	8	27	D
10/26/23 08:01	10/25/23	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Jones Douglas Edward	MI	O	COO	P	152	15.17	0	10	38	36	D
10/12/23 16:01	10/12/23	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Tobin James P	MI	D		P	46	15.19	0	3	17	20	D
10/11/23 16:21	10/11/23	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Naemura David H.	MI	O	CFO	P	150	15.03	0	10	New	10	D
1/18/23 17:04	1/13/23	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Jones Douglas Edward	MI	O	COO	P	45	17.91	0	3	27	12	D
10/11/22 19:09	10/11/22	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Quinlan Steven J.	MI	O	VP,CFO	P	58	11.63	0	5	18	33	D
10/4/22 18:43	10/3/22	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Boehm William T		D		P	28	13.89	0	2	9	23	D
9/28/22 17:29	9/28/22	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Jones Douglas Edward	MI	O	COO	P	100	14.31	0	7	254	10	D
9/28/22 17:27	9/28/22	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Adent John Edward	CO	DO	P,CEO	P	316	14.37	0	22	38	80	D
8/17/22 20:15	8/16/22	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Vetter Darci L	MI	D		P	24	21.83	0	1	387	1	D
8/10/22 14:27	7/27/22	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Borel James C	DE	D		P	148	22.70	0	7	123	12	D
8/4/22 19:03	8/2/22	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Green Ronald D	MI	D		P	34	22.50	0	2	16	11	D
8/2/22 14:28	7/29/22	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Adent John Edward	CO	DO	P,CEO	P	404	23.07	0	18	43	58	D
7/28/22 13:04	7/27/22	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Tobin James P	MI	D		P	46	22.98	0	2	17	14	D
1/28/22 18:43	1/25/22	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Jones Douglas Edward	MI	O	Chief Co	P	50	35.78	0	1	146	2	D
9/24/21 17:49	9/23/21	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Tobin James P	MI	D		P	43	42.92	0	1	9	12	D
3/27/20 18:12	3/25/20	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Adent John Edward	MI	DO	P,CEO	P	102	58.24	0	2	12	16	D
3/27/20 18:08	1/8/20	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Adent John Edward	MI	DO	P,CEO	P	99	65.40	0	2	12	14	D
3/27/20 17:58	3/26/20	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Tobin James P	MI	D		P	44	60.62	0	1	15	6	D
9/28/18 20:56	9/26/18	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Adent John Edward	CO	O	P,CEO	P	316	73.58	0	4	New	4	D
9/28/18 20:34	9/26/18	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Tobin James P	MI	D		P	37	73.37	0	1	12	5	D
7/31/17 14:41	7/27/17	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Tobin James P	MI	D		P	32	64.64	0	1	19	3	D
3/29/16 18:44	3/24/16	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Quinlan Steven J.	MI	O	VP,CFO	P	100	44.73	10	2	28	10	D	-1	-6	-7	-23	-5	-15	-10	-14	2	-1	-2	8	22	36
2/1/16 08:07	1/28/16	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Parnell Jack C		D		P	1	50.25	10	0	0	23	D	24	8	-8	-3	-11	-2	0	0	2	-5	-3	-9	6	24
9/24/15 18:13	9/22/15	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Quinlan Steven J.	MI	O	VP,CFO	P	50	47.17	10	1	16	8	D	21	20	-1	0	-16	-7	-10	-11	1	-7	0	17	-8	22
9/24/15 18:00	9/22/15	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Reed Thomas H		D		P	191	47.80	10	4	354	5	D	21	20	-1	0	-16	-7	-10	-11	1	-7	0	17	-8	22
8/5/15 16:19	8/3/15	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Yeutter Clayton K		D		P	29	58.32	15	1	New	1	D	50	32	21	34	17	18	0	1	-1	-3	-11	-5	-12	-5
4/21/15 14:02	4/20/15	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Calk Richard E Jr	MI	O	P,COO	P	249	45.84	8	5	New	5	D	41	9	10	-5	-7	-3	-2	-3	4	0	-1	5	6	3
7/28/14 14:41	7/24/14	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Quinlan Steven J.	MI	O	VP,CFO	P	40	42.96	10	1	16	7	D	49	9	-1	1	14	0	5	13	5	3	1	2	17	41
10/19/12 17:35	10/18/12	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Fischer A. Charles	MI	D		P	42	42.49	9	1	50	3	D	21	17	11	-2	7	-1	0	-1	2	3	5	12	21	65
5/21/12 17:38	5/21/12	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Yeutter Clayton K		D		P	10	39.00	5	0	3	8	I	56	-10	1	9	3	-1	0	0	-2	-2	12	4	10	40
1/3/12 13:06	12/27/11	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Yeutter Clayton K		D		P	114	30.92	11	4	102	7	I	30	-25	-32	-12	-17	-14	-7	-1	3	0	10	30	55	49
12/30/11 10:42	12/27/11	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Quinlan Steven J.	MI	O	VP,CFO	P	100	31.12	11	3	496	4	I	27	-27	-32	-11	-20	-10	-8	-1	0	0	6	27	50	49
12/28/11 11:03	12/23/11	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Fischer A. Charles	MI	D		P	31	30.91	12	1	100	2	D	27	-26	-31	-6	-20	-14	-10	-4	-3	0	5	28	48	44
10/13/11 17:30	10/11/11	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Yeutter Clayton K		D		P	5	34.87	11	0	4	4	I	78	4	-7	-21	6	8	14	9	1	-3	1	-17	0	14
8/24/11 17:49	8/23/11	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Boehm William T		D		P.d	18	35.06	9	1	100	1	D	78	24	-5	-15	-26	-11	-5	2	-3	0	-3	2	0	16
8/16/11 19:00	8/12/11	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Yeutter Clayton K		D		P.m	36	36.47	9	1	29	4	I	101	34	-4	-8	-19	-13	1	8	1	-11	-9	8	-5	6
8/16/11 18:35	8/4/11	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Crowder Richard T		D		P	19	38.11	9	1	100	1	D	101	34	-4	-8	-19	-13	1	8	1	-11	-9	8	-5	6
8/4/11 17:02	8/4/11	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Quinlan Steven J.	MI	O	VP,CFO	P	19	37.19	7	1	New	1	D	98	30	5	0	-8	-16	-15	-6	0	-6	-5	0	-9	3
8/3/11 13:44	8/1/11	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Yeutter Clayton K		D		P	13	41.98	7	0	9	3	I	96	29	3	-4	-10	-19	-19	-5	2	-1	-9	1	-12	0
8/2/11 18:14	8/1/11	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Fischer A. Charles	MI	D		P	40	39.97	7	1	New	1	D	106	35	11	-4	-4	-14	-14	1	2	-6	-8	3	-14	1
10/5/10 10:47	10/1/10	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Crowder Richard T		D		P.d	16	32.75	5	1	New	1	D	84	58	29	30	16	4	3	-3	3	4	6	28	27	-3
11/19/09 11:31	11/17/09	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Yeutter Clayton K		D		P.d	7	33.01	4	0	11	2	I	34	42	56	16	10	6	4	8	-2	-2	2	4	12	60
5/5/09 17:58	5/4/09	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Yeutter Clayton K		D		P.am	20	22.20	5	1	90	2	I	30	-14	-25	-16	9	3	-1	-6	0	1	11	33	45	79
5/5/09 17:42	5/4/09	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Yeutter Clayton K		D		P.m	20	22.20	5	1	New	1	I	30	-14	-25	-16	9	3	-1	-6	0	1	11	33	45	79
1/9/09 10:34	1/8/08	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Kodilla Kenneth V	MI	O	VP	P	14	24.71	4	1	22	3										-1	-5	8	-11	14	44
11/21/08 14:24	11/21/08	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Mozola Mark A		O	VP	P	22	21.78	7	1	25	5	D	62	-16	-15	-18	-12	-26	-18	-12	-4	4	9	3	1	52
7/28/08 17:47	7/25/08	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Yeutter Clayton K		D		P	26	25.90	7	1	New	1	I	101	39	12	6	2	15	10	3	5	4	-2	11	-8	12
2/21/08 10:30	10/5/07	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Kodilla Kenneth V	MI	O	VP	P.m	45	24.00	2	2	258	3	D	80	79	32	2	0	13	7	0	5	7	-4	-3	2	-5
11/20/07 20:50	11/19/07	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Current Richard R		O	VP,CFO	P	3	25.91	3	0	0	48	D	94	85	41	25	1	-4	-6	-8	-1	4	-2	6	-5	-10
1/11/06 15:01	1/9/06	NEOG	Health	Diagn	In Vitro & In Vivo Diagnostic	Current Richard R		O	VP CFO	P	2	20.45	2	0	0	22										0	-2	0	5	-19	-5

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y